Percutaneous coronary intervention (PCI) is a crucial diagnostic and therapeutic approach
for coronary heart disease. Contrast agents' exposure during PCI is associated with a risk of …

In hospitals, contrast‐induced acute kidney injury (CI‐AKI) is a major cause of renal failure.
This study evaluates berberine's (BBR) renal protection and its potential HDAC4 …

Introduction Acute kidney injury (AKI) defined by a substantial decrease in kidney function
within hours to days and is often irreversible with higher risk to chronic kidney disease …

Introduction Neurocognitive deficits after stroke are a common manifestation and pose a
significant impact on the quality of life for patients and families; however, little attention is …

Contrast-induced acute kidney injury (CI-AKI) has become the third leading cause of AKI
acquired in hospital, lacking of effective interventions. In the study, we identified the renal …

Purpose Contrast-induced acute kidney injury (CI-AKI) is the third most common cause of
hospital-acquired AKI. However, there is a paucity of efficacious interventions for the …

Drug-induced acute kidney injury (DI-AKI) is one of the leading causes of kidney injury, is
associated with high mortality and morbidity, and limits the clinical use of certain therapeutic …

The incidence of contrast-induced acute kidney injury (CI-AKI) has escalated to become the
third most prevalent cause of hospital-acquired AKI, with a lack of efficacious interventions …

Introduction Stroke patients develop cognitive impairment that, significantly impacting their
quality of life, their families, and the community as a whole, but they are not given attention …

This study evaluated the impact of Bioelectrical Impedance Vector Analysis (BIVA)-guided
hydration therapy on contrast-associated acute kidney injury (CA-AKI) in patients …